Retail sale of pharmaceutical products
HELZAMED AS
Operating profit
NOK −36,000
Equity
NOK −13,000
Incorporated
2024
Share capital
NOK 30,000
Key figures · 2025
Current ratio
15.96
Equity ratio
-158.9%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -460.9% | |
| Likviditet | ||
| Current ratio | 15.96 | |
| Working capital | 7k | |
| Soliditet | ||
| Equity ratio (%%) | -158.9% | |
| Debt-to-equity ratio | -1.63 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.